Discover how much you need to retire early and smart investment strategies to achieve it. Click for more on a strategy and ...
3d
Vial Initiates Phase 1 Trial of VIAL-INHBE, an INHBE (Activin E) siRNA for the Treatment of Obesity
Vial, a clinical-stage biotechnology company, announced that it is initiating the Phase 1 trial for a novel INHBE (Activin E) siRNA, which is being developed as a potentially best-in-class treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback